# DESCRIPTION

## BACKGROUND

- motivate UPS importance

## BRIEF SUMMARY

- outline CHIP-based methods

## DETAILED DESCRIPTION

- describe protein turnover regulation by CHIP and PKG

### Definitions

- define protein homeostasis and proteostasis
- define proteotoxicity and protein quality control
- define nucleic acid and related terms
- define peptide, polypeptide, and protein
- define phospho-mimetic amino acid substitution and related terms

### CHIP and Protein Homeostasis

- introduce protein misfolding and disease
- describe protein quality control pathways
- detail ubiquitin proteasome system
- explain CHIP protein structure and function
- introduce phosphorylation status of CHIP
- describe methods of inhibiting toxic protein accumulation
- detail nucleic acid sequence encoding CHIP
- describe vector preparation and delivery
- introduce viral vectors for gene delivery
- describe expression control sequences
- introduce synthetic mRNA constructs
- describe host cells for expression
- detail transfection, transformation, and transduction methods
- introduce increasing or inducing phosphorylation of CHIP
- describe agents that stimulate PKG activity
- introduce CHIP and protein homeostasis
- define altering a gene
- describe gene editing methods
- explain in vitro and in vivo methods
- describe cardiovascular dysfunction and disease
- detail myocardial ischemia-reperfusion injury
- describe transthyretin cardiac amyloidosis
- explain neurological dysfunction and disease
- describe proteinopathies
- outline method of treating disease caused by proteotoxicity
- describe composition and administration of CHIP-encoding nucleic acid sequence
- detail formulation and preparation of composition
- explain routes of administration
- define therapeutically effective amount
- describe monitoring therapeutic efficacy
- outline combination therapy with other treatments

### EXAMPLES

- introduce mouse models
- describe myocardial infarction procedure
- outline cultured cardiomyocyte studies
- detail protein analysis methods
- describe proteasome activity assay
- outline LDH/MTT cytotoxicity assay
- describe cycloheximide chase assay
- detail tissue histology and immunostaining
- outline quantitative real-time PCR
- describe PKG and CHIP/CHIP-S20A in vitro kinase assays

### Example 1

- demonstrate PKG activity regulates protein quality control in a CHIP-dependent manner

### Example 2

- demonstrate PKG directly phosphorylates mouse CHIP at Ser20 in cells

### Example 3

- demonstrate genetic alteration of CHIP S20 alters ischemic proteotoxicity in myocytes in vitro

### Example 4

- demonstrate PKG activity increases CHIP phosphorylation and protein expression
- demonstrate PKG activity counters proteotoxicity after myocardial infarction in vivo

### Example 5

- demonstrate CHIP S20 phosphorylation
- test thermodynamic impact on CHIP-Hsp70 binding
- examine CHIP-HSC70 interaction and protein half-life

### Example 6

- generate CHIP-S20E knock-in mice
- test cardioprotection against MI-proteotoxicity
- examine CHIP protein level and ubiquitinated proteins
- demonstrate CHIP-S20E enhanced functionality

